glp-1 advertising crackdown news Attorney General Brown Pushes Meta to Act on Misleading AI Weight Loss Ads - Hims to stop offering GLP-1
Description
The SELECT trial demonstrated that semaglutide 2.4 mg reduced major adverse cardiovascular events (heart attack, stroke, and cardiovascular death) by 20% in adults with overweight or obesity and established heart disease (Lincoff et al., SELECT trial, New England Journal of Medicine , 2023)
Is GLP-1 the same as Ozempic
Can I exercise on phentermine or GLP-1 medications
doi: 10.1155/2020/8073516 [DOI] [PMC free article] [PubMed] [Google Scholar] 95.Yoon G, Kim YK, Song J
Note: This product alone is not intended to diagnose, treat, cure, or prevent any disease
